New FDA SOUP/OTS Guidance: Managing Risk and Testing at Scale

45 minutes

Click for sound

This browser does not support HTML video.

Click for sound

Founder and CEO Erez Kaminski and former Principal Investigator, Device Security & Cyber Physical Systems for MITRE Gabriel Pascualy delve into the latest 2023 FDA guidances, with a particular focus on the use of SOUP and Off-The-Shelf Software (OTS) in medical devices and the content of premarket submissions for device software functions.

After answering audience questions, a brief demo on how Ketryx addresses the OTS management and risk management regarding the use of SOUP items.